» Articles » PMID: 11145975

Differential Gene Expression of Beta-1,4-galactosyltransferases I, II and V During Mouse Brain Development

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2001 Jan 9
PMID 11145975
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Since most brain glycoproteins from beta-1,4-galactosyltransferase (beta-1,4-GalT) I knockout mice were galactosylated without apparent reduction the gene expression of novel beta-1,4-GalTs II and V which are involved in N-linked oligosaccharide biosynthesis in addition to beta-1,4-GalT I was studied during mouse brain development. Isolation and characterization of beta-1,4-GalT II and V cDNAs from mouse brains indicates that they are also functioning in the brain. Northern blot analysis revealed that the beta-1,4-GalT I gene is expressed mainly in mid-embryonic stages, while the expression level of beta-1,4-GalT II transcript remains constant and of beta-1,4-GalT V transcript increases during mouse brain development after birth. In situ hybridization revealed that beta-1,4-GalT II and V signals are present in most neural cells, with a marked difference between them in the hippocampus of adult mouse brain tissue. The differential gene expression of beta-1,4-GalTs I, II and V during mouse brain development could affect the differential galactosylation of brain glycoproteins, as revealed by lectin blot analysis.

Citing Articles

Aggrecan and Hyaluronan: The Infamous Cartilage Polyelectrolytes - Then and Now.

Plaas A, Moran M, Sandy J, Hascall V Adv Exp Med Biol. 2023; 1402:3-29.

PMID: 37052843 DOI: 10.1007/978-3-031-25588-5_1.


High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia.

Ren Z, Huang X, Lv Q, Lei Y, Shi H, Wang F Front Genet. 2022; 13:882004.

PMID: 36568388 PMC: 9780537. DOI: 10.3389/fgene.2022.882004.


The Impact of β-1,4-Galactosyltransferase V on Microglial Function.

Wang X, Shi N, Hui M, Jin H, Gao S, Zhou Q Front Cell Neurosci. 2021; 15:723308.

PMID: 34539352 PMC: 8446519. DOI: 10.3389/fncel.2021.723308.


Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.

Canevari R, Marchi F, Domingues M, de Andrade V, Caldeira J, Verjovski-Almeida S Tumour Biol. 2016; 37(10):13855-13870.

PMID: 27485113 DOI: 10.1007/s13277-016-5133-8.


Quantitative analysis of glycans, related genes, and proteins in two human bone marrow stromal cell lines using an integrated strategy.

Li X, Li D, Pang X, Yang G, Deeg H, Guan F Exp Hematol. 2015; 43(9):760-9.e7.

PMID: 25936519 PMC: 4780331. DOI: 10.1016/j.exphem.2015.04.009.